ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Oropharyngeal discomfort | 22.12.03.015; 07.05.05.008 | - | - | Not Available |
Posterior reversible encephalopathy syndrome | 17.13.02.007 | 0.002002% | | |
Functional gastrointestinal disorder | 07.11.01.016 | 0.000334% | | Not Available |
Slow speech | 19.19.02.004; 17.02.08.016 | 0.001001% | | Not Available |
Mouth swelling | 23.04.01.020; 10.01.05.020; 07.05.04.007 | 0.000734% | | Not Available |
Anal incontinence | 17.05.01.021; 07.01.06.029 | 0.001802% | | |
Cerebellar haemorrhage | 17.08.01.046; 24.07.04.023 | 0.000334% | | Not Available |
Lymphadenopathy mediastinal | 22.09.03.006; 01.09.01.025 | 0.000334% | | Not Available |
Malignant pleural effusion | 16.32.03.014; 22.05.04.001 | 0.000334% | | Not Available |
Metastases to bone | 16.22.02.005; 15.09.03.006 | 0.009209% | | Not Available |
Metastases to lymph nodes | 16.22.02.006; 01.09.01.015 | 0.000834% | | Not Available |
Normal pressure hydrocephalus | 17.07.01.002 | 0.000334% | | Not Available |
Prostatic haemorrhage | 21.04.01.009; 24.07.03.028 | 0.000334% | | |
Throat cancer | 22.08.02.008; 16.19.02.007 | 0.000334% | | Not Available |
Urinary bladder haemorrhage | 20.03.01.023; 24.07.01.086 | 0.000667% | | Not Available |
Terminal state | 08.01.03.079 | 0.001001% | | Not Available |
Fear of falling | 19.06.03.008 | 0.001135% | | Not Available |
Metastases to bone marrow | 16.22.02.013; 01.05.01.022 | 0.000334% | | Not Available |
Metastases to meninges | 16.22.02.003; 17.02.10.012 | 0.000501% | | Not Available |
Foaming at mouth | 08.01.03.070; 17.02.05.056; 07.05.05.019 | 0.000734% | | Not Available |
Bladder tamponade | 24.07.01.064; 20.02.02.024 | 0.000334% | | Not Available |
Hormone-refractory prostate cancer | 21.04.02.007; 16.25.01.004 | 0.003570% | | Not Available |
Oncologic complication | 16.32.03.025 | 0.000501% | | Not Available |
Seizure like phenomena | 17.12.03.030 | 0.000667% | | Not Available |
Spinal pain | 08.01.08.030; 17.10.01.020; 15.02.01.008 | 0.001702% | | Not Available |
Abdominal lymphadenopathy | 07.11.01.018; 01.09.01.020 | 0.000334% | | Not Available |
Tongue discomfort | 07.14.02.019 | 0.001135% | | Not Available |
Biliary obstruction | 09.02.02.005 | 0.000501% | | Not Available |
Cardiac dysfunction | 02.11.01.004 | 0.000334% | | Not Available |
Drug effect less than expected | 08.06.01.036 | - | - | Not Available |